Pertuzumab/Trastuzumab Breast Cancer Therapy Is Associated With Complex Hemodynamic Abnormalities

Srikanth Koneru,Kimi Sato,Adam Goldberg,Vedha Sanghi,Alberto J. Montero,Richard A. Grimm,L. Leonardo Rodriguez,Brian P. Griffin,G. Thomas Budd,Patrick Collier,Balaji Tamarappoo,Milind Y. Desai,Zoran B. Popović

Pertuzumab/Trastuzumab Breast Cancer Therapy Is Associated With Complex Hemodynamic Abnormalities

2018

Srikanth Koneru
Kimi Sato
Adam Goldberg
Vedha Sanghi
Alberto J. Montero
Richard A. Grimm
L. Leonardo Rodriguez
Brian P. Griffin
G. Thomas Budd
Patrick Collier
Balaji Tamarappoo
Milind Y. Desai
Zoran B. Popović

Whereas breast cancer therapy may target cardiovascular system through side effects of surgery, chemotherapy, and radiation, interest has been focused on the impact of trastuzumab [(1)][1], a human epidermal growth factor receptor-2 (HER2) blocker, on left ventricular (LV) function. Maximizing HER2

Keywords:

Radiology
Human epidermal growth factor
Breast cancer
Hemodynamics
Oncology
Trastuzumab
Pertuzumab
Medicine
Chemotherapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations